Dr. Anna Krichevsky is an Associate Professor of Neurology at Brigham and Women’s Hospital and Harvard Medical School, Boston. She received her Ph.D. degree from the Hebrew University of Jerusalem, Israel, and completed postdoctoral training at BWH/HMS. As a postdoctoral fellow, Anna pioneered the work that led to the recognition of microRNA functions and RNA interference mechanisms in brain physiology and pathology. She performed the first successful RNA interference in mammalian neurons; contributed to the identification of first miRNAs in mammalian brain; developed first high-throughput arrays for miRNA expression profiling; and discovered the first oncogenic miRNA, miR-21, that is currently a promising target for various human diseases. 

Krichevsky laboratory has identified and investigated key regulatory RNAs involved in human brain tumors and neurodegenerative disorders such as Alzheimer’s disease and multiple sclerosis. Her laboratory also pioneered the identification of miRNA biomarkers for diagnostics and monitoring of primary and metastatic brain tumors. Dr. Krichevsky’s work has been evaluated as the “Must read” by the Faculty of 1000 and featured in the Boston Globe, HealthCanal, Science Daily, Thomson Reuters, International Innovations, and other periodicals. All her recent projects were based on successful collaborations that involved building diverse academic and industrial teams. Dr. Krichevsky gave numerous invited talks at various national and international meetings. She serves as a reviewer for the NIH and other governmental and private foundations, in USA and other countries. She also serves on the Executive Committee of the HMS Initiative for RNA Medicine, established to translate RNA research to clinical practice.